Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Reverse Total Shoulder Arthroplasty Shows Stable Results

By HospiMedica International staff writers
Posted on 08 Nov 2017
A new study concludes that reverse total shoulder arthroplasty (RTSA) can provide substantial and lasting improvement in patients younger than 60 years with limited treatment options.

Researchers at Balgrist University Hospital (Zurich, Switzerland) and the University of Zurich (UZH; Switzerland) conducted a study involving 20 patients (23 shoulders) with a mean age of 57 years, who underwent RTSA for massive, irreparable, tears of the rotator cuff muscles; the tears caused shoulder pseudoparalysis, resulting in little no ability to lift the arm. More...
Fifteen of the shoulders (65%) had undergone previous non-arthroplasty surgery. The patients were evaluated at a mean 11.7 years later in order to analyze long-term outcomes and complications.

The results revealed that most patients had substantial long-term improvement, with average constant score--a standard assessment accounting for shoulder motion, strength, daily activities, and pain--at the time of final-follow-up improving from 24 to 59 (out of 100). Patients' ratings of subjective shoulder value rose from 20% to 71%, with shoulder movement and strength increasing, and pain decreasing. Complications occurred in 39% of the shoulders, and further surgery was required in six shoulders; in two cases, the RTSA procedure was considered a failure. The study was published on October 18, 2017, in the Journal of Bone & Joint Surgery.

"In the absence of treatment alternatives, RTSA is a justifiable treatment for patients with a massive, irreparable rotator cuff tear before the age of 60,” concluded lead author Christian Gerber, MD, of the University of Zurich, and colleagues. “Despite a substantial risk of complications, most patients are satisfied with the outcomes of RTSA at follow-ups of a decade or longer.”

RTSA uses a convex glenoid (hemispheric ball) and concave humerus (articulating cup) to reconstruct the glenohumeral joint, which reverses the anatomical form of shoulder articulation. As a result, the center of rotation is moved inferiorly and medialized, allowing the deltoid to act on a longer fulcrum and have more mechanical advantage, so that it can substitute the deficient rotator cuff muscles in order to provide shoulder abduction. RTSA can be combined with latissimus dorsi transfer to assist with external rotation.

Related Links:
Balgrist University Hospital
University of Zurich

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.